Which of the Following Is an Important Component of Drug Accountability?

The answer

The important component of drug accountability is maintaining drug shipping and disposition records, documentation that tracks the investigational product from the moment it arrives until it is used, returned, or destroyed. Under Good Clinical Practice (GCP), accountability means being able to account for every unit of investigational agent at every stage.

A complete drug-accountability system documents the full lifecycle:

• Receipt — recording what arrived, quantity, lot/batch number, expiration date, and condition on delivery.
• Storage — keeping the product under required conditions (temperature, security, limited access) with logs.
• Dispensing — recording exactly which subject received which quantity, on what date, at what dose.
• Return — logging unused product returned by subjects.
• Disposition/disposal — documenting final destruction or return to the sponsor, with witnesses and records.

Because these records let anyone reconstruct the path of every dose, they are the heart of accountability, and why the correct choice is the option naming shipping and disposition (receipt-to-disposal) records.

Why the other options are wrong

Common distractors on this GCP item describe good practices that are not the accountability component:

• "Marketing the drug to potential subjects." Wrong and inappropriate. Promotion has nothing to do with accountability and would raise ethical concerns in a trial.
• "Recording only the number of subjects enrolled." Wrong. Enrollment counts are trial-management data, not a record of drug movement; they do not track quantities of product.
• "Analyzing the study's efficacy results." Wrong. Efficacy analysis is a downstream outcome measure, unrelated to physically accounting for the investigational agent.
• "Publishing the trial protocol." Wrong. Transparency in registration is important but is a separate obligation from tracking the drug supply.

Only the shipping-and-disposition-records option captures the receipt-through-disposal chain that defines accountability.

The bigger picture

Drug accountability protects subject safety and data integrity. If records are incomplete, investigators cannot prove subjects received the correct product and dose, cannot detect diversion or misuse, and cannot demonstrate that expired or excess product was properly destroyed. Regulators and monitors routinely audit these records, and gaps are among the most common GCP inspection findings.

Under ICH GCP, the investigator (or a designated pharmacist or qualified person) is responsible for accountability at the site, while the sponsor ensures adequate supply, timely shipment, and that records reconcile. Storage must follow the sponsor's specified conditions, and dispensing must follow the protocol. A typical accountability log captures date, subject ID, quantity dispensed, quantity returned, lot number, expiration, and the initials of the person performing each action.

The practical rule to remember for the exam: accountability is about tracing every unit of the investigational product across its whole lifecycle, from receipt and storage through dispensing, return, and final disposal, and the documentation that makes that traceability possible is the essential component.